Reproductive Health Innovation Summit 2022

Reproductive Health Innovation Summit

Connecting industry leaders to spark innovation, investment, access, and solutions across the reproductive health spectrum

Download the 2022 Agenda
Boston, USA
15-16 February, 2022

“As always, I am excited to engage with this community of inspiring women’s health innovators and learn about the new solutions bridging the healthcare gap for women globally.”

Erica Kantor, Head of Women’s Health, Sagentia Innovation

Spaces are filling fast - register your place today!

Testimonials & Success Stories

Why Attend

Reproductive health is set to hold a leading market share of women’s health industry, with an estimated global worth of $171 billion by 2027.

Start-ups, Femtech, and Technology innovators are driving the acceleration of new and improved solutions for the unmet needs of people’s reproductive health journeys.

The Reproductive Health Innovation Summit (15-16 February) is the destination for uncovering what is next in fertility, contraception, and maternal health, from AI and big data to genetic testing, laboratory automation, consumer wearables, non-hormonal devices and solutions, and new care delivery models.

Join us to:

  • Tackle the challenges that straddle the reproductive health sector, including funding, insurance coverage, access and DTC business-models.
  • Dive into 1 of our 3 leading innovation topics: Contraception, Fertility or Maternal Health, to discover the latest research, innovations, and sector-specific challenges and opportunities.
  • Network with the leaders and changemakers, with numerous 1-2-1 opportunities, investor clinics and interactive roundtables throughout the 2 days.

Add to the innovation, and attend alongside our leading network of, biotech’s, start-ups, Femtech, insurers, CRO’s, investors, medical device companies, researchers, pharmaceuticals, HCP’s and advocacy groups, to drive innovation at the convergence of healthcare and technology.

2022 Innovation Spotlight

Showcasing the most innovative and disruptive companies in reproductive health.

2022 FINALISTS WINNER ANNOUNCED

CONTRALINE

We would like to congratulate Contraline for winning the 2022 Reproductive Health Innovation Summit!

Here's a little bit about our showcase winner:
Contraline is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception. The company is developing ADAM, the world’s first long-lasting, non-hormonal, and non-permanent contraceptive for men. The company was founded in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, Virginia.

2022’S PRESTIGIOUS SELECTION COMMITTEE OF INVESTORS

2022 Partners

Platinum Partners

Gold Partners

Media Partners

2022 Speakers

 

Elena Gambon

VP Business Development
First Stop Health

Elena Gambon

VP Business Development
First Stop Health

Elena Gambon

VP Business Development
First Stop Health
 

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures
 

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds
 

Elizabeth Garner

Chief Medical Officer
Obseva

Elizabeth Garner is Chief Medical Officer at ObsEva, a Swiss women’s health specialty pharmaceutical company headquartered in Geneva. With over a decade of experience in the pharmaceutical industry, Dr. Garner has wide expertise in drug development, including clinical trial design and conduct, regulatory and FDA Advisory Committee strategy, support of commercial launch planning, medical affairs, and pharmacovigilance.

Elizabeth Garner

Chief Medical Officer
Obseva

Elizabeth Garner

Chief Medical Officer
Obseva

Elizabeth Garner is Chief Medical Officer at ObsEva, a Swiss women’s health specialty pharmaceutical company headquartered in Geneva. With over a decade of experience in the pharmaceutical industry, Dr. Garner has wide expertise in drug development, including clinical trial design and conduct, regulatory and FDA Advisory Committee strategy, support of commercial launch planning, medical affairs, and pharmacovigilance. As a member of ObsEva’s Executive Committee, she provides strategic leadership on the Company’s overall development strategy and frequently represents ObsEva to investor, Key Opinion Leader (KOL), and other key stakeholders.
From 2014 to 2019, Dr. Garner was Chief Medical Officer of Agile Therapeutics, located in Princeton, NJ. She played a crucial role during Agile’s 2014 Initial Public Offering and was instrumental in the Company’s Investor Relations, Communications, and Business Development strategies. Dr. Garner led the clinical development of Twirla®, Agile’s low-dose contraceptive patch, took the Company through an FDA dispute resolution process, and was the presenter and moderator for Agile’s successful FDA Advisory Committee meeting in October 2019, which led to FDA approval of Twirla® in February, 2020. She also led pre-launch activities, including commercial support, medical affairs, KOL development, and the pharmacovigilance and Medical Information programs.
Prior to her position at Agile, Dr. Garner was Vice President of Medical Affairs, Preventive Care at Myriad Genetics, where she managed the women’s health research, publication, and KOL development programs, provided medical and scientific input on Myriad’s marketing and new product strategies, served as its media spokesperson, and directed an experienced team of Field Medical Specialists. Before that, she was Senior Director at Abbott Laboratories, where she oversaw all clinical aspects of the global Phase 3 endometriosis development program for elagolix, which was FDA-approved in 2018.
From 2007 to 2011, Dr. Garner was Associate Director then Director of Clinical Research at Merck Research Laboratories. As a leader on the human papillomavirus (HPV) vaccine program she was instrumental in achieving successful outcomes on important regulatory submissions. Dr. Garner also served as chair of the Gardasil®9 HPV vaccine program Product Development Team, leading scientific, regulatory, global access and medical affairs strategies. Dr. Garner was the presenter and moderator for the successful 2010 FDA Gardasil® Advisory Committee Meeting. She also had substantial involvement in commercialization strategy and KOL development, and participated in due diligence on infectious disease and women’s health products.
Dr. Garner received joint M.D. and M.P.H degrees from Harvard Medical School and Harvard School of Public Health. She was trained in obstetrics and gynecology at Brigham and Women’s/Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at Brigham and Women’s/Dana Farber Cancer Institute. Prior to entering the pharmaceutical industry, Dr. Garner focused on academic clinical practice, basic science research in ovarian cancer, and teaching and mentorship of fellows, residents, and medical students at Harvard Medical School. She is an author on numerous peer-reviewed scientific papers.
Dr. Garner is a member of the Board of Directors of Kezar Life Sciences, a publicly traded company focused on the development of new therapies targeting protein homeostasis for the treatment of autoimmune diseases and cancer. She serves on the board’s audit and clinical strategy & execution committees. She is also on the Board of Directors of the Drug Information Association (DIA), a member-driven volunteer organization for global healthcare product development; she serves on the audit committee. She is on the Board of Directors and is Chair of the finance committee of the American Medical Women’s Association, a professional organization which functions at the local, national, and international level to advance women in medicine. Dr. Garner also serves on the Board of the Executive Women of New Jersey and was a 2018 honoree at its Salute to the Policy Makers gala, which recognizes executive women leaders across all industries. She is also on the Board of CorStone, a global non-profit organization focused on resilience in youth. Dr. Garner was a 2019 awardee of the PharmaVoice 100 Most Inspiring Individuals in the life sciences industry.

 

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson
 

Edio Zampaglione

Head of Global Medical Affairs & Outcomes
Organon

Edio Zampaglione

Head of Global Medical Affairs & Outcomes
Organon

Edio Zampaglione

Head of Global Medical Affairs & Outcomes
Organon
 

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.  Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.

 

Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.

 

Katie Williams

MPH, Technical Officer
FHI360

Katie Williams

MPH, Technical Officer
FHI360

Katie Williams

MPH, Technical Officer
FHI360
 

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility
 

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles
 

Nathanial DeNicola

Head Telehealth Committee
ACOG

Nathanial DeNicola

Head Telehealth Committee
ACOG

Nathanial DeNicola

Head Telehealth Committee
ACOG
 

Dr. Patrick Carroll

Chief Medical Officer
Hims & Hers

Dr. Patrick Carroll

Chief Medical Officer
Hims & Hers

Dr. Patrick Carroll

Chief Medical Officer
Hims & Hers
 

Akash Bakshi

CEO
Your Choice Therapeutics

Akash Bakshi

CEO
Your Choice Therapeutics

Akash Bakshi

CEO
Your Choice Therapeutics
 

Lisa Campo-Engelstein

PhD, Associate Professor
Preventive Medicine and Population Health

Lisa Campo-Engelstein

PhD, Associate Professor
Preventive Medicine and Population Health

Lisa Campo-Engelstein

PhD, Associate Professor
Preventive Medicine and Population Health
 

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association
 

Shelley Alpern

Director of Corporate Engagement
Rhia Ventures

Shelley Alpern

Director of Corporate Engagement
Rhia Ventures

Shelley Alpern

Director of Corporate Engagement
Rhia Ventures
 

Amanda Gorman

Founder & Clinical Director
Nest Collaborative

Amanda Gorman

Founder & Clinical Director
Nest Collaborative

Amanda Gorman

Founder & Clinical Director
Nest Collaborative
 

Sara Naseri

CEO
QVIN

Sara Naseri

CEO
QVIN

Sara Naseri

CEO
QVIN
 

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan
 

Katie Schubert

MPP, President & CEO
Society of Women's Health Research

Katie Schubert

MPP, President & CEO
Society of Women's Health Research

Katie Schubert

MPP, President & CEO
Society of Women's Health Research
 

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)
 

Heather Vahdat

Executive Director
Male Contraceptive Initiative

Heather Vahdat

Executive Director
Male Contraceptive Initiative

Heather Vahdat

Executive Director
Male Contraceptive Initiative
 

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical
 

Priyanka Jain

Co-Founder & CEO
Evvy

Priyanka Jain

Co-Founder & CEO
Evvy

Priyanka Jain

Co-Founder & CEO
Evvy
 

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital
 

Audrey Anderson Duckett

Chief Operating Officer
Be Girl

Audrey Anderson Duckett

Chief Operating Officer
Be Girl

Audrey Anderson Duckett

Chief Operating Officer
Be Girl
 

Brian T. Nguyen

Assistant Program Director, Section of Family Planning
LAC+USC Medical Center

Brian T. Nguyen

Assistant Program Director, Section of Family Planning
LAC+USC Medical Center

Brian T. Nguyen

Assistant Program Director, Section of Family Planning
LAC+USC Medical Center
 

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures
 

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria
 

Deena Shakir

Partner
LUX Capital

Deena Shakir

Partner
LUX Capital

Deena Shakir

Partner
LUX Capital
 

Casey Santiago

Managing Partner
Steelsky Ventures

Casey Albert Santiago has 20 years of global operating experience building, scaling and investing in women’s health companies. Casey is a Managing Partner at SteelSky Ventures, a female-led venture capital fund investing in early-stage companies that improve access, care, and outcomes in women's health. Prior to joining SteelSky, Casey invested in early-stage digital health & consumer health start-ups in partnership with Johnson & Johnson.

Casey Santiago

Managing Partner
Steelsky Ventures

Casey Santiago

Managing Partner
Steelsky Ventures

Casey Albert Santiago has 20 years of global operating experience building, scaling and investing in women’s health companies. Casey is a Managing Partner at SteelSky Ventures, a female-led venture capital fund investing in early-stage companies that improve access, care, and outcomes in women's health. Prior to joining SteelSky, Casey invested in early-stage digital health & consumer health start-ups in partnership with Johnson & Johnson. She was CEO/Founder of Kangu, a maternal health tech platform that was acquired in 2018, and was an early product leader at Kiva, which has facilitated billions of dollars in microloans to female entrepreneurs in the US and globally. Casey serves as an advisor to a number of venture-backed women’s health start-ups and speaks frequently on entrepreneurship and women’s health. She holds a BA from Wellesley College, an MBA from Columbia Business School.

 

Jackie Rotman

Founder
Center of Intimacy Justice

Jackie Rotman

Founder
Center of Intimacy Justice

Jackie Rotman

Founder
Center of Intimacy Justice
 

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio
 

Michelle Perugini

Co-Founder & CEO
Presagen

Michelle Perugini

Co-Founder & CEO
Presagen

Michelle Perugini

Co-Founder & CEO
Presagen
 

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions
 

Rachel Blank

Founder & CEO
Allara

Rachel Blank

Founder & CEO
Allara

Rachel Blank

Founder & CEO
Allara
 

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic
 

Alison Malmqvist

Deputy Director, Sexual & Reproductive Health
PSI

Alison Malmqvist

Deputy Director, Sexual & Reproductive Health
PSI

Alison Malmqvist

Deputy Director, Sexual & Reproductive Health
PSI
 

Emma Kemble

Engagement Manager
McKinsey & Company
​Emma Kemble is an engagement manager with McKinsey’s Pharmaceutical and Medical Products practice. She leads the firm’s research on FemTech and serves clients across the healthcare value chain (Pharma, Biotech, PBM, Payer, Pharmacy).

Emma Kemble

Engagement Manager
McKinsey & Company

Emma Kemble

Engagement Manager
McKinsey & Company
​Emma Kemble is an engagement manager with McKinsey’s Pharmaceutical and Medical Products practice. She leads the firm’s research on FemTech and serves clients across the healthcare value chain (Pharma, Biotech, PBM, Payer, Pharmacy). Emma has expertise in women’s health, market access, pricing, and pharmacy benefit management.
​Helped contraceptive provider to shape global go-to-market strategy

Prepared gyn oncology client for future value and market access hurdles and advised on incorporating value and access in both clinical and business development

Developed strategy and identified the next wave of growth for a pharmacy benefit manager

Assessed key trends in pharmaceutical pricing and access in the US and determined implications for client

​Emma earned a B.A. in Economics from Georgetown University. She took a sabbatical from McKinsey to join a healthcare venture in Bangladesh, aimed at developed a network of family and women’s health clinics in Bangladesh.
 

Amy Fan

Co-Founder
Twentyeight Health

Amy Fan

Co-Founder
Twentyeight Health

Amy Fan

Co-Founder
Twentyeight Health
 

Bruno van Tuykom

CEO & Co-Founder
Twentyeight Health

Bruno van Tuykom

CEO & Co-Founder
Twentyeight Health

Bruno van Tuykom

CEO & Co-Founder
Twentyeight Health
 

Sarah Cairns-Smith

Senior Advisor
Boston Consulting Group

Sarah Cairns-Smith

Senior Advisor
Boston Consulting Group

Sarah Cairns-Smith

Senior Advisor
Boston Consulting Group
 

Carli Sapir

Founding Partner
Amboy Street Ventures

Carli Sapir

Founding Partner
Amboy Street Ventures

Carli Sapir

Founding Partner
Amboy Street Ventures
 

Polly Rodriguez

CEO
Unbound

Polly Rodriguez

CEO
Unbound

Polly Rodriguez

CEO
Unbound
 

Lauren Wang

CEO
The Flex Company

Lauren Wang

CEO
The Flex Company

Lauren Wang

CEO
The Flex Company
 

Dr. Rem Koning

Assistant Professor
Harvard Business School

Dr. Rem Koning

Assistant Professor
Harvard Business School

Dr. Rem Koning

Assistant Professor
Harvard Business School
 

Dana Northcraft

JD (she/her) Director of Innovation & Partnerships
EMAA Project

Dana Northcraft

JD (she/her) Director of Innovation & Partnerships
EMAA Project

Dana Northcraft

JD (she/her) Director of Innovation & Partnerships
EMAA Project
 

Vrunda Desai

Head of Global Medical Affairs
CooperSurgical

Vrunda Desai

Head of Global Medical Affairs
CooperSurgical

Vrunda Desai

Head of Global Medical Affairs
CooperSurgical
 

Dr. Denny Sakkas

Scientific Director
Boston IVF

Dr. Denny Sakkas

Scientific Director
Boston IVF

Dr. Denny Sakkas

Scientific Director
Boston IVF
 

Dr.Lynn Westphal

Chief Medical Officer
Kindbody

Dr.Lynn Westphal

Chief Medical Officer
Kindbody

Dr.Lynn Westphal

Chief Medical Officer
Kindbody
 

Dr. Barbara Stegmann

Clinical Lead, Women's Health
Organon

Dr. Barbara Stegmann

Clinical Lead, Women's Health
Organon

Dr. Barbara Stegmann

Clinical Lead, Women's Health
Organon
 

Elizabeth Cherot

MD, Chief Medical Officer
Axia Women's Health

Dr. Elizabeth Cherot is Chief Medical Officer with Axia Women’s Health, a rapidly growing network of progressive, connected, and caring women’s health professionals with more 400 providers and nearly 200 locations across five states. She is an established and highly skilled physician with over 20 years of experience in obstetrics and gynecology.  In addition to her expert clinical skills, she is committed to improving OB/GYN care, reducing morbidity and mortality while implementing cost reduction and providing an efficient business model for today’s OB/GYN practice.

Elizabeth Cherot

MD, Chief Medical Officer
Axia Women's Health

Elizabeth Cherot

MD, Chief Medical Officer
Axia Women's Health

Dr. Elizabeth Cherot is Chief Medical Officer with Axia Women’s Health, a rapidly growing network of progressive, connected, and caring women’s health professionals with more 400 providers and nearly 200 locations across five states. She is an established and highly skilled physician with over 20 years of experience in obstetrics and gynecology.  In addition to her expert clinical skills, she is committed to improving OB/GYN care, reducing morbidity and mortality while implementing cost reduction and providing an efficient business model for today’s OB/GYN practice.

 

Dr. Cherot has been awarded numerous honors throughout her career including several National Excellence in Teaching Awards. She has also helped to pioneer the Enhanced Recovery after Surgery program in the United States, contributing to a significant reduction of opioid using in post-partum women.

 

In addition to being an accomplished clinician, Dr. Cherot holds an Executive MBA from Johns Hopkins University Carey School of Business. She resides in Central New Jersey with her husband and two children. 

 

Dr. Kristyn Brandi

Board Chair
Physicians for Reproductive Health

Dr. Kristyn Brandi

Board Chair
Physicians for Reproductive Health

Dr. Kristyn Brandi

Board Chair
Physicians for Reproductive Health
 

Melissa Grant

COO
Carafem

Melissa Grant

COO
Carafem

Melissa Grant

COO
Carafem
 

Monica Lee

Medical Director, Women's Health Obstetrics and Gynecology, ICON.
ICON

Monica Lee

Medical Director, Women's Health Obstetrics and Gynecology, ICON.
ICON

Monica Lee

Medical Director, Women's Health Obstetrics and Gynecology, ICON.
ICON
 

Sarah Swank

Counsel
Nixon Peabody LLP

As a former senior in-house counsel for two national health care systems, Sarah Swank provides strategic, regulatory and operational advice to health systems, hospitals and academic medical centers, as well as large national and regional physician organizations and telehealth and other startups.

Sarah Swank

Counsel
Nixon Peabody LLP

Sarah Swank

Counsel
Nixon Peabody LLP

As a former senior in-house counsel for two national health care systems, Sarah Swank provides strategic, regulatory and operational advice to health systems, hospitals and academic medical centers, as well as large national and regional physician organizations and telehealth and other startups.

 

Alexandra Busto

Associate, Healthcare
Nixon Peabody LLP

Alexandra Busto is an associate in the Health Care group. She works with academic medical centers, hospitals, long-term care facilities, surgery centers, foundations and clinics, medical groups/IPAs, accountable care organizations, and other entities affiliated with the health care industry. Alex also represents companies in the health information, medical device, and telehealth fields.

Alexandra Busto

Associate, Healthcare
Nixon Peabody LLP

Alexandra Busto

Associate, Healthcare
Nixon Peabody LLP

Alexandra Busto is an associate in the Health Care group. She works with academic medical centers, hospitals, long-term care facilities, surgery centers, foundations and clinics, medical groups/IPAs, accountable care organizations, and other entities affiliated with the health care industry. Alex also represents companies in the health information, medical device, and telehealth fields.

 

Polly Rodriguez

CEO & Co-Founder
Unbound

Polly Rodriguez

CEO & Co-Founder
Unbound

Polly Rodriguez

CEO & Co-Founder
Unbound
 

Dr. Kenneth Carson

Vice-President of Clinical Solutions
Tempus Labs

Dr. Kenneth Carson is a practicing physician and recognized expert in the area of real-world evidence generation.  After medical school graduation at the University of Southern California, he completed residency training in internal medicine at Duke University and fellowship training in hematology and medical oncology at Northwestern University.  Later, as a faculty member at Washington University in St.

Dr. Kenneth Carson

Vice-President of Clinical Solutions
Tempus Labs

Dr. Kenneth Carson

Vice-President of Clinical Solutions
Tempus Labs

Dr. Kenneth Carson is a practicing physician and recognized expert in the area of real-world evidence generation.  After medical school graduation at the University of Southern California, he completed residency training in internal medicine at Duke University and fellowship training in hematology and medical oncology at Northwestern University.  Later, as a faculty member at Washington University in St. Louis, he received a PhD in public health from the University of Illinois.  During his time as a Wash U faculty member, he developed and mentored a research team that used the large national databases from the department of Veterans Affairs to investigate treatment patterns and outcomes in patients with cancer and pre-cancerous conditions.  Based upon this research success, he became chief of hematology and oncology at the St. Louis VA medical center.  Five years ago, he transitioned the majority of his time to industry, working first at Flatiron Health in New York, and later at Tempus Labs in Chicago, where he is currently Vice-President of Clinical Solutions.  Both Flatiron and Tempus are major players in the rapidly growing industry of real-world data in oncology.  Today, in addition to seeing patients every week at Rush University, Dr. Carson works with a variety of pharmaceutical and provider stakeholders to solve major challenges in oncology drug development.

 

Cath Everett

VP of Product
Flo Health

Cath Everett

VP of Product
Flo Health

Cath Everett

VP of Product
Flo Health

Download 2022 agenda

Be the first to view our 2021 Reproductive Health Innovation Summit agenda!

Sessions include:

  • Investment, Innovation & Reproductive Health: Where does Technology Stand today?
  • The IVF Clinic Market of the Future: Exploring the Impact of PE investment
  • Male Reproductive Health & The Impact on Women's Health
  • Sex & Gender in Medicine, Research & Practice

Our agenda provides all the information you need to book your place at Reproductive Health Innovation Summit USA, access your copy today!


Download the Reproductive Health Innovation Summit Agenda

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

Covid-19 Update for attending Reproductive Health Innovation Summit, February 15th – 16th 2022

As of January 15th, 2022, a Covid-19 vaccination mandate will come in to affect in the city of Boston. This mandate means that anyone attending an event must be double vaccinated and provide proof of this prior to attending the event. Anyone with a medical or religious exemption is not permitted to attend any event in line with the Boston city mandate. Further details on the Covid-19 vaccination mandate can be found by clicking here.

The Boston Park Plaza hotel will be enforcing this for any event taking place within their hotel. For more information on what the Boston Park Plaza are doing to ensure the safety of guests and visitors to the hotel click here.

To ensure we meet all mandate and hotel rules, we will be asking anyone attending the Reproductive Health Innovation Summit to be double vaccinated and to provide proof of this by sending us a copy of your vaccination card via email. Anyone who is not double vaccinated will not be permitted to attend; as the venue will not accept testing in lieu of vaccination, and in line with the city of Boston mandate.

REGISTRATION

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

TICKET PRICES INCREASE IN

Preparing registration...

VENUE

Venue

50 Park Plaza, Boston, MA 02116, United States

Please click here for local hotel options.

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Women's Health Innovation Series: Women's Healthy Aging Summit

Women's Health Innovation Summit, Europe

Women's Health Innovation Summit 2022